arrow
S

Susanna Nikolaus

university of michigan system
H指数:53
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

987e: BIOMARKER-INFORMED THERAPY GUIDANCE IMPROVED CLINICAL OUTCOMES OF ANTI-TNF TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A MULTI-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE CLINICAL TRIAL (GUIDE-IBD)

987e: 生物标志物指导的疗法改善了炎症性肠病患者抗-TNF治疗的临床结局,该研究在一项多中心、随机、开放标签、前瞻性临床试验(GUIDE-IBD)中进行。

2025-07-030
PRE
Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease

粪便元蛋白质组学能够实现炎症性肠病患者缓解期的功能表征

2025-06-010
OA
Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn's disease
2023-09-2516
OAAI
DNA methyltransferase 3A controls intestinal epithelial barrier function and regeneration in the colon
2022-10-2112
OAAI
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naive Inflammatory Bowel Disease

外周血的详细转录景观表明在未经治疗的炎症性肠病中中性粒细胞活化增加

2022-01-1111
OAAI
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease
2021-06-01140
OA
Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
2019-11-01194
OAAI
Mucus Detachment by Host Metalloprotease Meprin β Requires Shedding of Its Inactive Pro-form, which Is Abrogated by the Pathogenic Protease RgpB
2017-11-0129
OA